{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T01:01:23Z","timestamp":1721437283883},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The National Centre for Research and Development, Poland","award":["Grant. No R13 0065 06","Grant. No STRATEGMED1\/233624\/5\/NCBR\/2014"],"award-info":[{"award-number":["Grant. No R13 0065 06","Grant. No STRATEGMED1\/233624\/5\/NCBR\/2014"]}]},{"name":"Polpharma Scientific Foundation, Poland","award":["III\/11\/2004"],"award-info":[{"award-number":["III\/11\/2004"]}]},{"name":"The National Science Centre, Poland","award":["Grant","No. 2012\/07\/N\/NZ3\/01687"],"award-info":[{"award-number":["Grant","No. 2012\/07\/N\/NZ3\/01687"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00005-017-0486-2","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T07:48:19Z","timestamp":1506412099000},"page":"145-159","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Biological and Pro-Angiogenic Properties of Genetically Modified Human Primary Myoblasts Overexpressing Placental Growth Factor in In Vitro and In Vivo Studies"],"prefix":"10.2478","volume":"66","author":[{"given":"Agnieszka","family":"Zimna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Wiernicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Kolanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Rozwadowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Malcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Labedz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Trzeciak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Chojnacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Bednarek-Rajewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemyslaw","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Kurpisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"key":"486_CR1","doi-asserted-by":"crossref","first-page":"16552","DOI":"10.1073\/pnas.0708145104","volume":"104","author":"A Asakura","year":"2007","unstructured":"Asakura A, Hirai H, Kablar B et al (2007) Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc Natl Acad Sci USA 104:16552\u201316557","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1538-7836.2003.00263.x","volume":"1","author":"M Autiero","year":"2003","unstructured":"Autiero M, Luttun A, Tjwa M et al (2003) Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1:1356\u20131370","journal-title":"J Thromb Haemost"},{"key":"486_CR3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijcard.2005.11.060","volume":"113","author":"C Becker","year":"2006","unstructured":"Becker C, Lacchini S, Muotri AR et al (2006) Skeletal muscle cells expressing VEGF induce capillary formation and reduce cardiac injury in rats. Int J Cardiol 113:348\u2013354","journal-title":"Int J Cardiol"},{"key":"486_CR4","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1074\/jbc.271.6.3154","volume":"271","author":"Y Cao","year":"1996","unstructured":"Cao Y, Chen H, Zhou L et al (1996) Heterodimers of placenta growth factor\/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1\/KDR. J Biol Chem 271:3154\u20133162","journal-title":"J Biol Chem"},{"key":"486_CR5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1590\/S1808-86942011000200015","volume":"77","author":"AT Carna\u00faba","year":"2011","unstructured":"Carna\u00faba AT, Farias VV, Santos N et al (2011) Influence of gender on the vestibular evoked myogenic potential. Braz J Otorhinolaryngol 77:245\u2013248","journal-title":"Braz J Otorhinolaryngol"},{"key":"486_CR6","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1074\/jbc.270.13.7717","volume":"270","author":"J DiSalvo","year":"1995","unstructured":"DiSalvo J, Bayne ML, Conn G et al (1995) Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer. J Biol Chem 270:7717\u20137723","journal-title":"J Biol Chem"},{"issue":"Suppl K","key":"486_CR7","doi-asserted-by":"crossref","first-page":"K11","DOI":"10.1093\/eurheartj\/sun050","volume":"10","author":"JJ Gavira","year":"2008","unstructured":"Gavira JJ, Abizanda G, Caro D et al (2008) Skeletal myoblasts for cardiac repair in animal models. Eur Heart J Suppl 10(Suppl K):K11\u2013K15","journal-title":"Eur Heart J Suppl"},{"key":"486_CR8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1096\/fj.05-4481fje","volume":"20","author":"B Gigante","year":"2006","unstructured":"Gigante B, Morlino G, Gentile MT et al (2006) PlGF\u2212\/\u2212eNos\u2212\/\u2212 mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia. FASEB J 20:970\u2013972","journal-title":"FASEB J"},{"key":"486_CR9","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jtcvs.2010.10.054","volume":"141","author":"M Gmeiner","year":"2011","unstructured":"Gmeiner M, Zimpfer D, Holfeld J et al (2011) Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor. J Thorac Cardiovasc Surg 141:1238\u20131245","journal-title":"J Thorac Cardiovasc Surg"},{"key":"486_CR10","first-page":"2696","volume":"61","author":"CJ Green","year":"2001","unstructured":"Green CJ, Lichtlen P, Huynh NT et al (2001) Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 61:2696\u20132703","journal-title":"Cancer Res"},{"key":"486_CR11","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/ars.2009.2471","volume":"11","author":"H Haider","year":"2009","unstructured":"Haider H, Akbar SA, Ashraf M (2009) Angiomyogenesis for myocardial repair. Antioxid Redox Signal 11:1929\u20131944","journal-title":"Antioxid Redox Signal"},{"key":"486_CR12","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jacc.2005.11.064","volume":"47","author":"H Iwama","year":"2006","unstructured":"Iwama H, Uemura S, Naya N et al (2006) Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol 47:1559\u20131567","journal-title":"J Am Coll Cardiol"},{"key":"486_CR13","doi-asserted-by":"crossref","first-page":"e24872","DOI":"10.1371\/journal.pone.0024872","volume":"6","author":"H Iwasaki","year":"2011","unstructured":"Iwasaki H, Kawamoto A, Tjwa M et al (2011) PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors. PLoS One 6:e24872","journal-title":"PLoS One"},{"key":"486_CR14","first-page":"59","volume":"8","author":"M Kawasuji","year":"2002","unstructured":"Kawasuji M (2002) Therapeutic angiogenesis for ischemic heart disease. Ann Thorac Cardiovasc Surg 8:59\u201361","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"486_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2014.02.009","volume":"173","author":"TJ Kolanowski","year":"2014","unstructured":"Kolanowski TJ, Rozwadowska N, Malcher A et al (2014) In vitro and in vivo characteristics of connexin 43-modified human skeletal myoblasts as candidates for prospective stem cell therapy for the failing heart. Int J Cardiol 173:55\u201364","journal-title":"Int J Cardiol"},{"key":"486_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.onc.1201545","volume":"16","author":"E Landgren","year":"1998","unstructured":"Landgren E, Schiller P, Cao Y et al (1998) Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt. Oncogene 16:359\u2013367","journal-title":"Oncogene"},{"key":"486_CR17","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.88.20.9267","volume":"88","author":"D Maglione","year":"1991","unstructured":"Maglione D, Guerriero V, Viglietto G et al (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267\u20139271","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pcad.2007.02.002","volume":"50","author":"P Menasch\u00e9","year":"2007","unstructured":"Menasch\u00e9 P (2007) Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis 50:7\u201317","journal-title":"Prog Cardiovasc Dis"},{"key":"486_CR19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.yjmcc.2007.11.009","volume":"45","author":"P Menasch\u00e9","year":"2008","unstructured":"Menasch\u00e9 P (2008a) Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol 45:545\u2013553","journal-title":"J Mol Cell Cardiol"},{"key":"486_CR20","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2008.07.066","volume":"52","author":"P Menasch\u00e9","year":"2008","unstructured":"Menasch\u00e9 P (2008b) Skeletal myoblasts for cardiac repair: act II. J Am Coll Cardiol 52:1881\u20131883","journal-title":"J Am Coll Cardiol"},{"key":"486_CR21","doi-asserted-by":"crossref","first-page":"e41736","DOI":"10.1371\/journal.pone.0041736","volume":"7","author":"Y Nakamura","year":"2012","unstructured":"Nakamura Y, Asakura Y, Piras BA et al (2012) Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium. PLoS One 7:e41736","journal-title":"PLoS One"},{"key":"486_CR22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ejheart.2008.08.002","volume":"10","author":"M Perez-Ilzarbe","year":"2008","unstructured":"Perez-Ilzarbe M, Agbulut O, Pelacho B et al (2008) Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail 10:1065\u20131072","journal-title":"Eur J Heart Fail"},{"key":"486_CR23","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/sj.mt.6300175","volume":"15","author":"TT Rissanen","year":"2007","unstructured":"Rissanen TT, Yl\u00e4-Herttuala S (2007) Current status of cardiovascular gene therapy. Mol Ther 15:1233\u20131247","journal-title":"Mol Ther"},{"key":"486_CR24","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","volume":"125","author":"VL Roger","year":"2012","unstructured":"Roger VL, Go AS, Lloyd-Jones DM et al (2012) Heart disease and stroke statistics 2012-update. A report from the American Heart Association. Circulation 125:e2\u2013e220","journal-title":"Circulation"},{"key":"486_CR25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/path.2408","volume":"216","author":"C Roncal","year":"2008","unstructured":"Roncal C, Buysschaert I, Chorianopoulos E et al (2008) Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance. J Pathol 216:236\u2013244","journal-title":"J Pathol"},{"key":"486_CR26","first-page":"233","volume":"57","author":"N Rozwadowska","year":"2002","unstructured":"Rozwadowska N, Fiszer D, Siminiak T et al (2002) Evaluation of in vitro culture of human myoblasts for tissue autotransplants to the post-infarcted heart. Pol Heart J 57:233\u2013237","journal-title":"Pol Heart J"},{"key":"486_CR27","first-page":"213","volume":"7","author":"A Sawano","year":"1996","unstructured":"Sawano A, Takahashi T, Yamaguchi S et al (1996) FIt-I but not KDR\/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213\u2013221","journal-title":"Cell Growth Differ"},{"key":"486_CR28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/dbio.1999.9565","volume":"218","author":"P Seale","year":"2000","unstructured":"Seale P, Rudnicki MA (2000) A new look at the origin, function, and -stem-cell status of muscle satellite cells. Dev Biol 218:115\u2013124","journal-title":"Dev Biol"},{"key":"486_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1534-5807(01)00049-1","volume":"1","author":"P Seale","year":"2001","unstructured":"Seale P, Asakura A, Rudnicki MA (2001) The potential of muscle stem cells. Dev Cell 1:333\u2013342","journal-title":"Dev Cell"},{"key":"486_CR30","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1253\/circj.CJ-08-1067","volume":"73","author":"Y Takeda","year":"2009","unstructured":"Takeda Y, Uemura S, Iwama H et al (2009) Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction. Circ J 73:1674\u20131682","journal-title":"Circ J"},{"key":"486_CR31","unstructured":"World Health Organization (2012) Cardiovascular Diseases, Statistics on chronic diseases and risk factors. \n                        http:\/\/www.who.int\/topics\/cardiovascular_diseases\/en\/index.html"},{"key":"486_CR32","first-page":"517","volume":"76","author":"M Ziche","year":"1997","unstructured":"Ziche M, Maglione D, Ribatti D et al (1997) Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Investig 76:517\u2013531","journal-title":"Lab Investig"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-017-0486-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-017-0486-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-017-0486-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:01Z","timestamp":1704228541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-017-0486-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["486"],"URL":"https:\/\/doi.org\/10.1007\/s00005-017-0486-2","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,26]]}}}